-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A collaborative team led by Professor Li Jian's laboratory at Monash University, Australia, recently published a paper online in the journal Nature Communications, reporting for the first time the development of a new generation of polypeptide antibiotic F365 (QPX9003)
Since this century, bacterial resistance has become a huge threat to human health worldwide
Polymyxins, first discovered in the 1940s, are lipopeptides produced by Paenibacillus polymyxa
The team of Professor Li Jian of Monash University used chemical biological methods to systematically change multiple non-conserved positions in the molecular structure of polymyxin, realizing the separation of therapeutic efficacy and toxicity for the first time, and successfully developed a new generation of polypeptide antibiotics F365 ( QPX9003)
▲Chemical structure and lipopeptide design strategy of polymyxin
Through systematic analysis of the structure-activity model of polymyxin, Professor Li Jian's team found that the N-terminal fatty acyl group, the 3-diaminobutyric acid (Dab) residue and the 6- and 7-amino acid residues are the most common in natural polymyxins.
▲ Nephrotoxicity, acute toxicity, and in vitro activity of polymyxins and lead compounds in mice
Experiments show that for Pseudomonas aeruginosa and Acinetobacter baumannii, the activity of F365 is 2 times and 8 times higher than that of polymyxin B, respectively
Transcriptomic analysis showed that Acinetobacter baumannii gene expression was significantly affected after polymyxin and F365 treatment
▲Transcriptome changes in Acinetobacter baumannii AB5075 and HK-2 cells after treatment with polymyxin B, colistin, F287, F319 and F365
Matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry imaging (ME-SALDI-MS) results revealed very different distribution, accumulation, and metabolism of F365 compared with polymyxin B and colistin in mouse kidney tissue
▲Matrix-enhanced surface-assisted laser desorption/ionization mass spectrometry imaging of the distribution, accumulation and metabolism of polymyxin and F365 in mouse kidney
References:
[1] Roberts, KD, Zhu, Y.